RxSight, Inc. Stock-Based Compensation
RxSight, Inc. (RXST) reported Stock-Based Compensation of $15.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- RxSight, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $7.46M, a 12.66% decline year-over-year.
- RxSight, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $7.95M, a 11.27% increase year-over-year.
- RxSight, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $7.82M, a 7.35% increase year-over-year.
- RxSight, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $8.11M, a 23.75% increase year-over-year.
- RxSight, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $31.61M, a 28.32% increase from fiscal 2024.
- RxSight, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $24.64M, a 56.45% increase from fiscal 2023.
- RxSight, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $15.75M, a 38.16% increase from fiscal 2022.
- RxSight, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $11.40M, a 50.46% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.41M 10-Q · filed 2026-08-05 | $23.23M derived: sum of 3 quarters · filed 2026-08-05 | $31.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.95M 10-Q · filed 2026-05-06 | $15.76M derived: sum of 2 quarters · filed 2026-05-06 | $23.87M derived: sum of 3 quarters · filed 2026-05-06 | $32.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.93M derived: sum of 2 quarters · filed 2026-02-25 | $24.47M derived: sum of 3 quarters · filed 2026-08-05 | $31.61M 10-K · filed 2026-02-25 |
| 2025-09-30 | $8.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $16.66M derived: sum of 2 quarters · filed 2026-08-05 | $23.80M 10-Q · filed 2025-11-05 | $31.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $8.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.69M 10-Q · filed 2026-08-05 | $22.97M derived: sum of 3 quarters · filed 2026-08-05 | $29.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $7.14M 10-Q · filed 2026-05-06 | $14.42M derived: sum of 2 quarters · filed 2026-05-06 | $20.97M derived: sum of 3 quarters · filed 2026-05-06 | $27.08M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.83M derived: sum of 2 quarters · filed 2026-02-25 | $19.94M derived: sum of 3 quarters · filed 2026-02-25 | $24.64M 10-K · filed 2026-02-25 |
| 2024-09-30 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $12.66M derived: sum of 2 quarters · filed 2025-11-05 | $17.35M 10-Q · filed 2025-11-05 | $21.78M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $6.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.80M 10-Q · filed 2025-08-07 | $15.23M derived: sum of 3 quarters · filed 2026-02-25 | $19.30M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $4.70M 10-Q · filed 2025-05-07 | $9.12M derived: sum of 2 quarters · filed 2026-02-25 | $13.19M derived: sum of 3 quarters · filed 2026-02-25 | $17.15M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.50M derived: sum of 2 quarters · filed 2026-02-25 | $12.45M derived: sum of 3 quarters · filed 2026-02-25 | $15.75M 10-K · filed 2026-02-25 |
| 2023-09-30 | $4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $8.03M derived: sum of 2 quarters · filed 2024-11-07 | $11.32M 10-Q · filed 2024-11-07 | $14.28M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $7.25M 10-Q · filed 2024-08-05 | $10.21M derived: sum of 3 quarters · filed 2025-02-25 | $13.09M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $3.29M 10-Q · filed 2024-05-06 | $6.26M derived: sum of 2 quarters · filed 2025-02-25 | $9.14M derived: sum of 3 quarters · filed 2025-02-25 | $12.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.84M derived: sum of 2 quarters · filed 2025-02-25 | $8.75M derived: sum of 3 quarters · filed 2025-02-25 | $11.40M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.79M derived: sum of 2 quarters · filed 2023-11-09 | $8.44M 10-Q · filed 2023-11-09 | $11.35M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.55M 10-Q · filed 2023-08-07 | $8.47M derived: sum of 3 quarters · filed 2023-08-07 | $10.48M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $2.65M 10-Q · filed 2023-05-09 | $5.57M derived: sum of 2 quarters · filed 2023-05-09 | $7.58M derived: sum of 3 quarters · filed 2023-05-09 | $8.98M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $4.93M derived: sum of 2 quarters · filed 2023-03-06 | $6.34M derived: sum of 3 quarters · filed 2023-03-06 | $7.58M 10-K · filed 2023-03-06 |
| 2021-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $3.42M derived: sum of 2 quarters · filed 2022-11-07 | $4.66M 10-Q · filed 2022-11-07 | $5.89M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.65M 10-Q · filed 2022-08-08 | $3.88M derived: sum of 3 quarters · filed 2022-08-08 | $5.12M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $1.24M 10-Q · filed 2022-05-05 | $2.48M derived: sum of 2 quarters · filed 2022-05-05 | $3.72M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $2.48M derived: sum of 2 quarters · filed 2022-03-08 | $4.18M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.95M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.71M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |